Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1925 of 2400 entries
View as:

Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00333398 Org: User:
Start: 06/30/06 End: 08/31/06 Due: 08/31/07

Epi Cystic Hydatid Disease Peru

Phase: N/A Priority: Normal
NCT ID: NCT00138346 Org: User:
Start: 08/31/04 End: 04/30/07 Due: 04/30/08

Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Phase: N/A Priority: Normal
NCT ID: NCT03881696 Org: User:
Start: 07/22/19 End: 06/30/25 Due: 06/30/26

Empiric Therapy of Mucopurulent Cervicitis (MPC)

Phase: N/A Priority: Normal
NCT ID: NCT01072136 Org: User:
Start: 03/31/10 End: 12/31/11 Due: 12/31/12

Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications

Phase: N/A Priority: Normal
NCT ID: NCT01949116 Org: User:
Start: 01/31/14 End: 12/08/16 Due: 12/08/17

The Influence of Malnutrition, Diabetes Mellitus, and Helminth Infections on Biosignatures in Latent Tuberculosis in a South Indian Population

Phase: N/A Priority: Normal
NCT ID: NCT04526613 Org: User:
Start: 04/19/21 End: 06/25/25 Due: 06/25/26

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

Phase: N/A Priority: Normal
NCT ID: NCT05398809 Org: User:
Start: 01/18/23 End: 12/01/27 Due: 12/01/28

Safety and Survival of Genetically Modified White Blood Cells in HIV-infected Twins The Gemini Study

Phase: N/A Priority: Normal
NCT ID: NCT04799483 Org: User:
Start: 01/05/01 End: 01/30/30 Due: 01/30/31

Plasmodium and Other Parasites in Pregnant Women and Children Around Margibi and Montserrado Counties, Liberia

Phase: N/A Priority: Normal
NCT ID: NCT03719599 Org: User:
Start: 10/01/19 End: 02/04/21 Due: 02/04/22

Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

Phase: N/A Priority: Normal
NCT ID: NCT00001475 Org: User:
Start: 06/30/95 End: 06/30/02 Due: 06/30/03

A Longitudinal Systems Biological Analysis of Naturally Acquired Malaria Immunity in Mali

Phase: N/A Priority: Normal
NCT ID: NCT01322581 Org: User:
Start: 05/01/11 End: 03/29/22 Due: 03/29/23

Thorough QT/QTC (TQT) Clinical Trial to Evaluate the Effect of Zoliflodacin on Cardiac Repolarization in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03613649 Org: User:
Start: 09/25/18 End: 01/02/19 Due: 01/02/20

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

Phase: N/A Priority: Normal
NCT ID: NCT00001353 Org: User:
Start: 03/31/93 End: 03/31/02 Due: 03/31/03

Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03878121 Org: User:
Start: 04/17/19 End: 10/15/25 Due: 10/15/26

Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT01946880 Org: User:
Start: 11/20/13 End: 07/03/19 Due: 07/03/20

Alternative Oseltamivir Dosing Strategies

Phase: N/A Priority: Normal
NCT ID: NCT00334529 Org: User:
Start: 06/05/06 End: 04/10/07 Due: 04/10/08

Directly Observed Therapy in HIV Infected Adolescent Focus Groups

Phase: N/A Priority: Normal
NCT ID: NCT00079729 Org: User:
Start: 04/30/04 End: 07/31/04 Due: 07/31/05

Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIV.

Phase: N/A Priority: Normal
NCT ID: NCT06332339 Org: User:
Start: 03/15/24 End: 11/11/26 Due: 11/11/27

Retrospective Chart Review of Candida Fungemia

Phase: N/A Priority: Normal
NCT ID: NCT03827330 Org: User:
Start: 01/03/19 End: 11/18/20 Due: 11/18/21

Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only

Phase: N/A Priority: Normal
NCT ID: NCT06721585 Org: User:
Start: 07/10/24 End: 07/31/25 Due: 07/31/26

Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women

Phase: N/A Priority: Normal
NCT ID: NCT03164564 Org: User:
Start: 11/07/17 End: 11/30/24 Due: 11/30/25

Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor

Phase: N/A Priority: Normal
NCT ID: NCT02069080 Org: User:
Start: 02/20/14 End: 07/10/18 Due: 07/10/19

Phase I STEBVax in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00974935 Org: User:
Start: 02/28/11 End: 03/31/15 Due: 03/31/16

Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm

Phase: N/A Priority: Normal
NCT ID: NCT00076817 Org: User:
Start: 06/30/06 End: 09/30/08 Due: 09/30/09

Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01289717 Org: User:
Start: 03/31/11 End: 06/30/16 Due: 06/30/17